Vijaya Diagnostic Centre Ltd.
NSE: VIJAYA · Healthcare
Volume collapse to 37% of average at 52-week high proximity signals exhaustion; premium 77x P/E valuation leaves no margin for error…
Q1 FY27 net profit surged 37.6% YoY with 120bps margin expansion to 22.17%, confirmed ₹2 dividend (200% payout), and strategic ₹46 crore North-East acquisition demonstrate operational leverage and management execution.
Volume has collapsed to 37% of 20-day average at 52-week high proximity while RSI remains neutral at 52.99 after 71% 6-month gain—classic exhaustion signal; analyst consensus target of ₹1,160 implies 23.4% downside.
Free: 5 Forecasts and 5 Debates a month. Log in with your mobile number.
-
Bearish 28 Sep 2026 → now Scores 28 Oct 2026₹1,501.40 → ₹1,501.40 0.0%
Every verdict and forecast here is dated and scored when it matures — right or wrong. The first scored results publish a month after launch.
How we score →
Bullzeye Financial